BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT00828009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
BIOLOGICAL: Tecemotide
DRUG: carboplatin
DRUG: cyclophosphamide
DRUG: paclitaxel
RADIATION: radiotherapy

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]